2007 Publications Listing

Journal Articles

  1. Abrams DJ, Earley MJ, Sporton SC, Kistler PM, Gatzoulis MA, Mullen MJ, Till JA, Cullen S, Walker F, Lowe MD, Deanfield JE, Schilling RJ. Comparison of noncontact and electroanatomic mapping to identify scar and arrhythmia late after the Fontan procedure. Circulation 2007;115(13):1738-46.
  2. Ahimastos AA, Aggarwal A, D'Orsa K, Formosa M, White AJ, Savarirayan R, Dart A, Kingwell B. Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. JAMA 2007;298(13):1539-47.
  3. Ahrens I, Peter K, Bode C. Factor Xa-inhibition in interventional cardiology. Hamostaseologie 2007;27(5):328-32.
  4. Ahrens I, Schwarz M, Peter K, Bode C. Therapeutic inhibitors of platelet aggregation – from aspirin to integrin blockers. J Transfus Med Hemother 2007;34(1):44-54.
  5. Ahrens I, Smith BK, Bode C, Peter K. Direct thrombin inhibition with bivalirudin as an antithrombotic strategy in general and interventional cardiology. Expert Opin Drug Metab Toxicol 2007;3(4):609-620.
  6. Ajani AE, Yan BP, Clark DJ, Eccleston D, Walton A, Lew R, Meehan A, Brennan A, Reid C, Duffy SJ; on behalf of the Melbourne Interventional Group (MIG) Investigators. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents. Heart Lung Circ 2007;16(4):269-73.
  7. Barton DA, Dawood T, Lambert EA, Esler MD, Haikerwal D, Brenchley C, Socratous F, Kaye DM, Schlaich MP, Hickie I, Lambert GW. Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J Hypertens 2007;25(10):2117-24.
  8. Bassler N, Loeffler C, Mangin P, Yuan Y, Schwarz M, Hagemeyer CE, Eisenhardt SU, Ahrens I, Bode C, Jackson SP, Peter K. A mechanistic model for paradoxical platelet activation by ligand-mimetic IIb3 (GPIIb/IIIa) antagonists. Arterioscler Thromb Vasc Biol 2007;27(3):e9-15.
  9. Becker AC, Sliwa K, Stewart S, Libhaber E, Essop MR. Acute coronary syndromes in black African patients with human immunodeficiency virus infection : initial results of the clinical and angiographic features. Cardiovasc J Afr 2007;18(3 Suppl):S12-4.
  10. Bradley SJ, Kingwell BA, Canny BJ, McConell GK. Skeletal muscle neuronal nitric oxide synthase micro protein is reduced in people with impaired glucose homeostasis and is not normalized by exercise training. Metabolism 2007;56(10):1405-11.
  11. Cameron J, Worrall-Carter L, Driscoll A, New G, Stewart S. Extent of heart failure self-care as an endpoint to patient education: a literature review. Br J Card Nursing 2007;2(4):188-97.
  12. Chin-Dusting JPF, Willems L, Kaye DM. L-arginine transporters in cardiovascular disease: a novel therapeutic target. Pharmacol Ther 2007;116(3):428-36.
  13. Clark RA, Driscoll A, Nottage J, McLennan S, Coombe DM, Bamford EJ, Wilkinson D, Stewart S. Inequitable provision of optimal services for patients with chronic heart failure: a national geo-mapping study. Med J Aust 2007;186(4):169-73.
  14. Clark RA, Eckert KA, Stewart S, Phillips SM, Yallop JJ, Tonkin AM, Krum H. Rural and urban differentials in primary care management of chronic heart failure: new data from the CASE study. Med J Aust 2007;186(9):441-5.
  15. Clark RA, Inglis SC, McAlister FA, Cleland JG, Stewart S. Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. BMJ 2007;334(7600):942-50.
  16. Clark RA, Yallop JJ, Piterman L, Croucher J, Tonkin A, Stewart S, Krum H; on behalf of the CHAT Study Team. Adherence, adaptation and acceptance of elderly chronic heart failure patients to receiving healthcare via telephone-monitoring. Eur J Heart Fail 2007;9(11):1104-11.
  17. Dart AM, Cameron JD, Gatzka CD, Willson K, Liang Y-L, Berry KL, Wing LMH, Reid CM, Ryan P, Beilin LJ, Jennings GLR, Johnston CI, McNeil JJ, MacDonald GJ, Morgan TO, West MJ, Kingwell BA. Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial. Hypertension 2007;49(6):1242-7.
  18. Dart AM, Otterstad JE, Kirwan BA, Parker JD, de Brouwer S, Poole-Wilson PA, Lubsen J, on behalf of the ACTION investigators. Predictive value of local and core laboratory echocardiographic assessment of cardiac function in patients with chronic stable angina: the ACTION study. Eur J Echocardiogr 2007;8(4):275-83.
  19. Dawood T, Anderson J, Barton D, Lambert E, Esler M, Hotchkin E, Haikerwal D, Kaye, D, Lambert G. Reduced overflow of BDNF from the brain is linked with suicide risk in depressive illness. Mol Psychiatr 2007;12(11):981-3.
  20. Dawood T, Lambert EA, Barton DA, Laude D, Elghozi J-L, Esler MD, Haikerwal H, Kaye DM, Hotchkin EJ, Lambert GW. Specific serotonin reuptake inhibition in major depressive disorder adversely affects novel markers of cardiac risk. Hypertens Res 2007;30(4):285-93.
  21. Dawson AP, McLennan SN, Schiller SD, Jull GA, Hodges PW, Stewart S. Interventions to prevent back pain and back injury in nurses: a systematic review. Occup Environ Med 2007;64(10):642-50.
  22. Eikelis N, Wiesner G, Lambert G, Esler M. Brain leptin resistance in human obesity revisited. Regul Pept 2007;139(1-3):45-51.
  23. Eisenhardt SU, Schwarz M, Bassler N, Peter K. Subtractive single-chain antibody (scFv) phage-display: tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules. Nat Protoc 2007;2(12):3063-73.
  24. Eisenhardt SU, Schwarz M, Schallner N, Soosairajah J, Bassler N, Huang D, Bode C, Peter K. Generation of activation-specific human anti-M2 single-chain antibodies as potential diagnostic tools and therapeutic agents. Blood 2007;109(8):3521-8.
  25. Esler M, Lambert E. Hypertension, SNS overactivity and the brain: interactions with peripheral organs – psychological influences and stress and target organ damage. Dialog Cardiovasc Med 2007;12:183-91.
  26. Esler M, Lambert E, Alvarenga M, Socratous F, Richards R, Barton D, Pier C, Brenchley C, Dawood T, Hastings J, Guo L, Haikerwal D, Kaye D, Jennings G, Kalff V, Kelly M, Wiesner G, Lambert G. Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor. Stress 2007;10(3):295-304.
  27. Esler M, Schwarz R. Management of hypertension complicated by psychiatric comorbidity. J Clin Hypertens 2007;9(9):708-13.
  28. Fang L, Gao XM, Moore XL, Kiriazis H, Su Y, Ming Z, Lim YL, Dart AM, Du XJ. Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. J Mol Cell Cardiol 2007;43(5):535-44.
  29. Fang L, Moore XL, Gao XM, Dart AM, Lim YL, Du XJ. Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo. Life Sci 2007;80(23):2154-60.
  30. Fujii A, Allen TJ, Nestel PJ. A 1,3-diacylglycerol-rich oil induces less atherosclerosis and lowers plasma cholesterol in diabetic apoE-deficient mice. Atherosclerosis 2007;193(1):55-61.
  31. Gaynor L, Gallasch T, Yorkston E, Stewart S, Turner C. Where do all the undergraduate and new graduate nurses go and why? A search for empirical research evidence. J Adv Nurs 2007;24(2):26-32.
  32. Gould PA, Kong G, Kalff V, Duffy SJ, Taylor AJ, Kelly MJ, Kaye DM. Improvement in cardiac adrenergic function post biventricular pacing for heart failure. Europace 2007;9(9):751-6.
  33. Hagemeyer CE, Schwarz M, Peter K. Single-chain antibodies as new antithrombotic drugs. Semin Thromb Hemost 2007;33(2):185-95.
  34. Hein LK, Meikle PJ, Hopwood JJ, Fuller M. Secondary sphingolipid accumulation in a macrophage model of Gaucher disease. Mol Genet Metab 2007;92(4):336-345.
  35. Hevener AL, Olefsky JM, Reichart D, Nguyen MT, Bandyopadyhay G, Leung HY, Watt MJ, Benner C, Febbraio MA, Nguyen AK, Folian B, Subramaniam S, Gonzalez FJ, Glass CK, Ricote M. Macrophage PPAR is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J Clin Invest 2007;117(6):1658-69.
  36. Hoang A, Murphy AJ, Coughlan MT, Thomas MC, Forbes JM, O'Brien R, Cooper ME, Chin-Dusting JP, Sviridov D. Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties. Diabetologia 2007;50(8):1770-9.
  37. Inglis SC, Stewart S, Papachan A, Vaghela V, Libhaber C, Veriava Y, Sliwa K. Anaemia and renal function in heart failure due to idiopathic dilated cardiomyopathy. Eur J Heart Fail 2007;9(4):384-90.
  38. Kalman JM, Kistler PM, Waldo AL. Localization of focal atrial tachycardias--back to the future...when (old) electrophysiologic first principles complement sophisticated technology. J Cardiovasc Electrophysiol 2007;18(1):7-8.
  39. Kaye DM, Krum H. Drug discovery for heart failure: a new era or the end of the pipeline? Nat Rev Drug Discov 2007;6(2):127-39.
  40. Kaye DM, Preovolos A, Marshall T, Byrne M, Hoshijima M, Hajjar R, Mariani JA, Pepe S, Chien KR, Power JM. Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals. J Am Coll Cardiol 2007;50(3):253-60.
  41. Kingwell B, Boutouyrie P. Genetic influences on the arterial wall. Clin Exp Pharmacol Physiol 2007;34(7):652-7.
  42. Kingwell BA, Ahimastos AA. Arterial stiffness and coronary ischemic disease. Adv Cardiol 2007;44:125-38.
  43. Kistler PM. The left atrial appendage: not just an innocent bystander. J Cardiovasc Electrophysiol 2007;18(5):465-6.
  44. Kistler PM. Catheter ablation techniques in managing arrhythmias. Aust Fam Physician 2007;36(7):512-7.
  45. Kistler PM, Habersberger J. Management of atrial fibrillation. Aust Fam Physician 2007;36(7):506-8,511.
  46. Kistler PM, Ho SY, Rajappan K, Morper M, Harris S, Abrams D, Sporton SC, Schilling RJ. Electrophysiologic and anatomic characterization of sites resistant to electrical isolation during circumferential pulmonary vein ablation for atrial fibrillation: a prospective study. J Cardiovasc Electrophysiol 2007;18(12):1282-8.
  47. Kistler PM, Obeyesekere MN. Pharmacologic management of tachycardia. Aust Fam Physician 2007;36(7):500-5.
  48. Kistler PM, Schilling RJ, Rajappan K, Sporton SC. Image integration for atrial fibrillation ablation--pearls and pitfalls. Heart Rhythm 2007;4(9):1216-21.
  49. Lambert E, Dawood T, Esler M, Barton D, Eikelis N, Bayles R, Lambert G. Psychological stress and the development of heart disease. Curr Psych Rev 2007;3(4):252-8.
  50. Lambert E, Straznicky N, Eikelis N, Esler M, Dawood T, Masuo K, Schlaich M, Lambert G. Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. J Hypertens 2007;25(7):1411-9.
  51. Lambert E, Straznicky N, Schlaich M, Esler M, Dawood T, Hotchkin E, Lambert G. Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension 2007;50(5):862-8.
  52. Lambert GW, Schlaich MP, Esler MD. Brain derived neurotrophic factor (BDNF) release from the human brain in patients with Type 2 diabetes-possible influence of venous anatomy and comorbid major depressive disorder. Diabetologia 2007;50(9):2027-8.
  53. Liew R, Rajappan K, Gupta D, Kistler P, Schilling R. Percutaneous epicardial ablation reverses ventricular tachycardia mediated cardiomyopathy. J Interv Card Electrophysiol 2007;18(3):265-7.
  54. Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S, Reid J, Van Zwieten PA. The sympathetic nervous system and the metabolic syndrome. J Hypertens 2007;25(5):909-20.
  55. Marasco SF, Esmore DS, Richardson M, Bailey M, Negri J, Rowland M, Kaye D, Bergin PJ. Prolonged cardiac allograft ischemic time--no impact on long-term survival but at what cost? Clin Transplant 2007;21(3):321-9.
  56. McConell GK, Bradley SJ, Stephens TJ, Canny BJ, Kingwell BA, Lee-Young RS. Skeletal muscle nNOS protein content is increased by exercise training in humans. Am J Physiol Endocrinol Metab 2007;293(2):R821-8.
  57. Moore XL, Tan SL, Lo CY, Fang L, Su YD, Gao XM, Woodcock EA, Summers RJ, Tregear GW, Bathgate RA, Du XJ. Relaxin antagonizes hypertrophy and apoptosis in neonatal rat cardiomyocytes. Endocrinology 2007;148(4):1582-9.
  58. Murphy A, White A, Nair R, Kingwell B, Duffy S, Chin-Dusting J, Woollard K. C-reactive protein and FcRIIa functional polymorphisms are not associated with clinical presentation of stable and unstable angina. Thromb Haemost 2007;97(4):681-2.
  59. Nestel P. Nutritional evidence still lacks consistency. Curr Opin Lipidol 2007;18(1):1-2.
  60. Nestel P, Fujii A, Zhang L. An isoflavone metabolite reduces arterial stiffness and blood pressure in overweight men and postmenopausal women. Atherosclerosis 2007;192(1):184-9.
  61. Nestel P, Lyu R, Low LP, Sheu WH, Nitiyanant W, Saito I, Tan CE. Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Asia Pac J Clin Nutr 2007;16(2):362-7.
  62. Ooi EM, Watts GF, Barrett PH, Chan DC, Clifton PM, Ji J, Nestel PJ. Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome. Asia Pac J Clin Nutr 2007;16(4):624-31.
  63. Ritchie RH, Quinn JM, Cao AH, Drummond GR, Kaye DM, Favaloro JM, Proietto J, Delbridge LM. The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivo. J Mol Cell Cardiol 2007;42(6):1119-28.
  64. Roberts-Thomson KC, Kistler PM, Haqqani HM, McGavigan AD, Hillock RJ, Stevenson IH, Morton JB, Vohra JK, Sparks PB, Kalman JM. Focal atrial tachycardias arising from the right atrial appendage: electrocardiographic and electrophysiologic characteristics and radiofrequency ablation. J Cardiovasc Electrophysiol 2007;18(4):367-72.
  65. Santiago FS, Ishii H, Shafi S, Khurana R, Kanellakis P, Bhindi R, Ramirez MJ, Bobik A, Martin JF, Chesterman CN, Zachary IC, Khachigian LM. Yin Yang-1 inhibits vascular smooth muscle cell growth and intimal thickening by repressing p21WAF1/Cip1 transcription and p21WAF1/Cip1-Cdk4-cyclin D1 assembly. Circ Res 2007;101(2):146-55.
  66. Schlaich MP, Delles C, Schmieder RE. Involvement of endothelial mechanisms in L-arginine-induced alterations of renal haemodynamics in humans. J Hypertens 2007;25(7):1515-6.
  67. Schlaich MP, Lambert EA, Sobotka PA, Lambert GW, Esler MD. Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. Hypertension 2007;49(5):e27.
  68. Schlaich MP, Lambert GW, Lambert EA, Esler MD. Letter by Schlaich et al regarding article, "Relationship between central sympathetic drive and magnetic resonance imaging determined left ventricular mass in essential hypertension". Circulation 2007;116(17):e416.
  69. Straub A, Breuer M, Wendel HP, Peter K, Dietz K, Ziemer G. Critical temperature ranges of hypothermia-induced platelet activation: Possible implications for cooling patients in cardiac surgery. Thromb Haemost 2007;97(4):608-16.
  70. Sviridov D, Nestel P, Watts G. Statins and metabolism of high density lipoprotein. Cardiovasc Hematol Agents Med Chem 2007;5(3):215-21.
  71. Sviridov D, Nestel PJ. Genetic factors affecting HDL levels, structure, metabolism and function. Curr Opin Lipidol 2007;18(2):157-63.
  72. Szollosi I, Krum H, Kaye D, Naughton MT. Sleep apnea in heart failure increases heart rate variability and sympathetic dominance. Sleep 2007;30(11):1509-14.
  73. Thomas MC, Nestel PJ. Management of dyslipidaemia in patients with Type 2 diabetes in Australian primary care. Med J Aust 2007;186(3):128-30.
  74. Thompson DR, Stewart S. Handmaiden or right-hand man: is the relationship between doctors and nurses still therapeutic? Int J Cardiol 2007;118(2):139-40.
  75. Thompson DR, Watson R, Stewart S. Nursing and midwifery: time for an amicable divorce? Int J Nurs Stud 2007;44(4):523-4.
  76. Tibazarwa KB, Ntyintyane L, Stewart S, Wilkinson D, Sliwa K. Cardiovascular screening and hypertension in an African population : heart awareness day in Soweto. Cardiovasc J Afr 2007;18(3 Suppl):S29-31.
  77. Vaddadi G, Lambert E, Corcoran SJ, Esler MD. Postural syncope: mechanisms and management. Med J Aust 2007;187(5):299-304.
  78. van der Merwe J, Leong JY, Kaye D, Opat S, Bergin PJ, Taylor AJ, Rosenfeldt F. Antioxidant therapy for severe cardiac failure Induced by iron overload secondary to dyserythropoietic anaemia. Heart Lung Circ 2007;16(5):394-7.
  79. Venardos KM, Kaye DM. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review. Curr Med Chem 2007;14(14):1539-49.
  80. von zur Muehlen C, von Elverfeldt D, Bassler N, Neudorfer I, Steitz B, Petri-Fink B, Hofmann H, Bode C, Peter K. Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques. Atherosclerosis 2007;193(1):102-11.
  81. Wein L, Wein S, Haas SJ, Shaw J, Krum H. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials. Arch Intern Med 2007;167(14):1476-86.
  82. White AJ, Duffy SJ, Walton AS, Ng JF, Rice GE, Mukherjee S, Shaw JA, Jennings GL, Dart AM, Kingwell BA. Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary disease. Cardiovasc Res 2007;75(4):813-20.
  83. Wong C, Marwick TH. Obesity cardiomyopathy: pathogenesis and pathophysiology. Nat Clin Pract Cardiovasc Med 2007;4(8):436-43.
  84. Wong C, Marwick TH. Obesity cardiomyopathy: diagnosis and therapeutic implications. Nat Clin Pract Cardiovasc Med 2007;4(9):480-90.
  85. Woollard KJ, Chin-Dusting J. Therapeutic targeting of P-selectin in atherosclerosis. Inflamm Allergy Drug Targets 2007;6(1):69-74.
  86. Xu Q, Ming ZQ, Dart AM, Du XJ. Optimizing dosage of ketamine and xylazine in murine echocardiography. Clin Exp Pharmacol Physiol 2007;34(5):499-507.
  87. Yan BP, Gurvitch R, Duffy SJ, Clark DJ, Sebastian M, New G, Warren R, Lefkovits J, Lew R, Brennan AL, Reid C, Andrianopoulos N, Ajani AE. An evaluation of octogenarians undergoing percutaneous coronary intervention from the Melbourne Interventional Group registry. Catheter Cardiovasc Interv 2007;70(7):928-36.
  88. Yang Z, Venardos K, Jones E, Morris BJ, Chin-Dusting J, Kaye D. Identification of a novel polymorphism in the 3'UTR of the L-arginine transporter gene SLC7A1. Contribution to hypertension and endothelial dysfunction. Circulation 2007;115(10):1269-74.
  89. Zhang W-Z, Lang C, Kaye DM. Determination of plasma free 3-nitrotyrosine and tyrosine by reversed-phase liquid chromatography with 4-fluoro-7-nitrobenzofurazan derivitization. Biomed Chromatogr 2007;21(3):273-8.
  90. Zirlik A, Maier C, Gerdes N, MacFarlane L, Soosairajah J, Bavendiek U, Ahrens I, Ernst S, Bassler N, Missiou A, Patko Z, Aikawa M, Schonbeck U, Bode C, Libby P, Peter K. CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. Circulation 2007;115(12):1571-80.



Book Chapters

  1. Lambert GW, Dawood T. Psychosomatic heart disease: role of sympathetic and sympathoadrenal processes. In: Fink G (ed) Encyclopedia of Stress, 2nd edition. 2007. Academic Press, Elsevier, UK. pp. 292-6.
  2. Sviridov D, Bukrinsky MI, Kingwell BA, Hoy J. HDL in health and disease: effects of exercise and HIV infection on HDL metabolism. In: Fielding CJ (ed) High-Density Lipoproteins: From Basic Biology to Clinical Aspects. 2007. Wiley-VCH, Germany. pp355-74.
  3. Kingwell BA, Ahimastos AA. Arterial Stiffness and Coronary Ischemic Disease. Adv Cardiol. 2007; 44:125-38.



Consultation in the Heart Centre is only by referral from a Medical Practitioner.



Please follow the link to find further information



‘This just doesn’t happen to people like me.’  aged 50...

Support US


Donate or Volunteer for research study. See how you can help.

Copyright © Alferd Health Victoria 2013 | Login